Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 20/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6061291 | 0.80 | CNR2 (0.73) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL13503318 | 0.78 | CNR2 (1.00) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL13503320 | 0.78 | CNR2 (1.00) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL541605 | 0.77 | CNR2 (0.62) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL541606 | 0.77 | CNR2 (0.62) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL13069566 | 0.76 | CNR2 (1.00) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL13503371 | 0.76 | CNR2 (0.79) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL13141747 | 0.76 | CNR2 (0.61) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL13069958 | 0.76 | CNR2 (0.80) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL541764 | 0.75 | CNR2 (1.00) | CNR2CYP2C9CYP3A4CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1878725-A2 | Pyrimidine derivatives and their use as CB2 modulators | GLAXO GROUP LIMITED (GB) | 2008-01-16 | — | — | EP | disclosed |